Insulet SmartAdjust is an interoperable, automated glycemic control software that connects to an insulin pump and continuous glucose monitor to automatically adjust insulin delivery. The technology was previously approved only for management of Type 1 diabetes, according to an Aug. 26 news release from the FDA.
Individuals with Type 2 diabetes typically manage insulin levels by manually checking blood glucose levels and self-administering insulin one or more times a day.
The Insulet SmartAdjust technology was cleared through the FDA’s 510(k) premarket pathway.
